top of page

COVID-19 highlights the acute need for non-invasive, point-of-care, remote monitoring

hemodynamic measurement solutions. Find out how CPS meets the need.

Sensydia in the news

January 6, 2026

Sensydia Announces AMA Cat III CPT® Code for Noninvasive AI Hemodynamic Assessment

Groundbreaking code will facilitate use, adoption, and pathway for reimbursement of noninvasive AI hemodynamic assessment, including Sensydia’s Cardiac Performance System (CPS™). The new CPT code, 1036T, was published December 30, 2025, and will be effective July 1, 2026.

Sensydia Announces American Medical Association Category III CPT® Code for Noninvasive AI Hemodynamic Assessment

Sensydia Announces American Medical Association Category III CPT® Code for Noninvasive AI Hemodynamic Assessment

Sensydia Announces American Medical Association Category III CPT® Code for Noninvasive AI Hemodynamic Assessment

Sensydia Awarded Second Phase of $3M NIH Grant Award to Demonstrate Clinical Utility of Cardiac Performance System (CPS™)

Sensydia Awarded Second Phase of $3M NIH Grant Award to Demonstrate Clinical Utility of Cardiac Performance System (CPS™)

Sensydia Awarded Second Phase of $3M NIH Grant Award to Demonstrate Clinical Utility of Cardiac Performance System (CPS™)

Rusty Page appointed President and Chief Operating Officer of Sensydia.

Rusty Page appointed President and Chief Operating Officer of Sensydia.

Sensydia Appoints Rusty Page as President and Chief Operating Officer to Support Growth and Commercialization of the Cardiac Performance System (CPS™)

Sensydia’s Cardiac Performance System (CPS™) is designed for fast, safe, and non-invasive cardiac performance assessment that can be performed almost anywhere, avoiding the need to visit a catheterization lab. Source: Sensydia.

Sensydia’s Cardiac Performance System (CPS™) is designed for fast, safe, and non-invasive cardiac performance assessment that can be performed almost anywhere, avoiding the need to visit a catheterization lab. Source: Sensydia.

Sensydia Announces First Patient Enrolled in Pivotal Study of Non-Invasive Cardiac Performance System (CPS™)

Clinical data presented at ACC 2025 shows Sensydia CPS™ provides accurate assessment of mean pulmonary artery pressure non-invasively

Clinical data presented at ACC 2025 shows Sensydia CPS™ provides accurate assessment of mean pulmonary artery pressure non-invasively

Clinical data presented at ACC 2025 shows Sensydia CPS™ provides accurate assessment of mean pulmonary artery pressure non-invasively

Sensydia Completes Fifth Study for Heart-Sound AI

Sensydia Completes Fifth Study for Heart-Sound AI

Sensydia Completes Fifth Study for Heart-Sound AI

bottom of page